Ophelia Raises $50 Million In Series B Funding, Led by Tiger Global, To Expand Its Novel Approach To Opioid Addiction Treatment

Ophelia, a digital provider organization of medication-assisted treatment (MAT) for opioid addiction, has raised a $50 million Series B investment led by Tiger Global. The round includes funding from Menlo Ventures, General Catalyst, Refactor Capital, 640 Oxford Ventures, Interplay Ventures, PillPack founder Elliot Cohen, and Good Friends, the fund launched by the founders of Warby Parker, Harry's, and Allbirds. The funding will enable Ophelia to expand its treatment program to more consumers and primary care professionals across the United States, integrate with additional payers and partners, and develop its primary care professional recruitment, training, and support platform.

Ophelia . . .